These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

106 related articles for article (PubMed ID: 5652673)

  • 1. Efficiency of the synergistic infection of L cells by groups of damaged vaccinia virus particles, MR.
    Kim KS; Sharp DG
    Virology; 1968 May; 35(1):112-20. PubMed ID: 5652673
    [No Abstract]   [Full Text] [Related]  

  • 2. Poxvirus specific cytopathic effect in interferon-treated L cells.
    Horak I; Jungwirth C; Bodo G
    Virology; 1971 Aug; 45(2):456-62. PubMed ID: 5106893
    [No Abstract]   [Full Text] [Related]  

  • 3. The influence of DEAE-dextran on plain and synergistic plaque formation by two poxviruses.
    Kim KS; Sharp DG
    J Gen Virol; 1969 Jun; 4(4):505-12. PubMed ID: 5803271
    [No Abstract]   [Full Text] [Related]  

  • 4. The prevention of early vaccinia-virus-induced cytopathic effects by inhibition of protein synthesis.
    Bablanian R
    J Gen Virol; 1968 Jul; 3(1):51-61. PubMed ID: 4234470
    [No Abstract]   [Full Text] [Related]  

  • 5. [Reactivation within the poxvirus group. 3. Reactivation of thermally inactivated vaccinia virus irradiated by ultraviolet rays].
    Mazur B
    Med Dosw Mikrobiol; 1969; 21(2):175-82. PubMed ID: 5348189
    [No Abstract]   [Full Text] [Related]  

  • 6. Rate of inactivation of smallpox and vaccinia viruses by fixatives used in histological methods.
    Potajallo U; Towiańska A; Dabrowski J
    Biul Inst Med Morsk Gdansk; 1968; 19(1):49-57. PubMed ID: 4300247
    [No Abstract]   [Full Text] [Related]  

  • 7. Resistance of the region of DNA coding ts40 marker of vaccinia virus to certain inactivating factors. Brief report.
    Ghendon YZ; Sitnikov BS
    Arch Gesamte Virusforsch; 1970; 29(1):101-4. PubMed ID: 5452661
    [No Abstract]   [Full Text] [Related]  

  • 8. Multiplicity reactivation and radiation survival of aggregated vaccinia virus. Calculation of plaque titer based on MR and particle aggregation seen in the electron microscope.
    Sharp DG; Kim KS
    Virology; 1966 Jul; 29(3):359-66. PubMed ID: 5922451
    [No Abstract]   [Full Text] [Related]  

  • 9. ["Rescue" of the rct40 plus-marker of vaccinia virus in different methods of inactivation of the donor virus].
    Sitnikov BS; Gendon IuZ
    Vopr Virusol; 1970; 15(3):278-83. PubMed ID: 5472067
    [No Abstract]   [Full Text] [Related]  

  • 10. Multiplicity reactivation of vaccinia virus particles treated with nitrogen mustard.
    Kim KS; Sharp DG
    J Virol; 1967 Feb; 1(1):45-9. PubMed ID: 5623957
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Defective vaccinia virus particles in interferon-treated infected cells.
    Esteban M
    Virology; 1984 Feb; 133(1):220-7. PubMed ID: 6702105
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Homologous inhibition with heated and ultraviolet-treated vaccinia virus in cultures of L cells.
    GALASSO GJ; SHARP DG
    Virology; 1963 May; 20():1-13. PubMed ID: 13946210
    [No Abstract]   [Full Text] [Related]  

  • 13. Rescue of vesicular stomatitis virus from interferon-induced resistance by superinfection with vaccinia virus. II. Effect of UV-inactivated vaccinia and metabolic inhibitors.
    Thacore HR; Youngner JS
    Virology; 1973 Dec; 56(2):512-22. PubMed ID: 4357054
    [No Abstract]   [Full Text] [Related]  

  • 14. Regulation of biosynthesis of secondary metabolites. XI. Induction of variants in Streptomyces aureofaciens and the specificity of mutagens.
    Mracek M; Blumauerová M; Palecková F; Hostálek Z
    Mutat Res; 1969; 7(1):19-24. PubMed ID: 5801074
    [No Abstract]   [Full Text] [Related]  

  • 15. Effect of some proteolytic enzymes on the plaque titer of vaccinia and rabbitpox viruses.
    Kim KS; Dalton D; Sharp DG
    Virology; 1969 Aug; 38(4):503-11. PubMed ID: 5803943
    [No Abstract]   [Full Text] [Related]  

  • 16. [Inactivation of formaldehyde by semicarbazide in disinfectant tests with viruses].
    Schoenemann W
    Zentralbl Bakteriol Mikrobiol Hyg B Umwelthyg Krankenhaushyg Arbeitshyg Prav Med; 1986 Oct; 182(5-6):525-36. PubMed ID: 3028010
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mechansims of vesicular stomatitis virus-induced cytopathic effects. II. Inhibition of macromolecular synthesis induced by infectious and defective-interfering particles.
    Baxt B; Bablanian R
    Virology; 1976 Jul; 72(2):383-92. PubMed ID: 181907
    [No Abstract]   [Full Text] [Related]  

  • 18. Molluscum contagiosum -- a defective poxvirus?
    Shand JH; Gibson P; Gregory DW; Cooper RJ; Keir HM; Postlethwaite R
    J Gen Virol; 1976 Nov; 33(2):281-95. PubMed ID: 11275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Resistance of viruses of the subgroup smallpox-vaccinia to treaments primarily damaging the protein coat of the nucleic component of the virus].
    Sitnikov BS; Gendom IuZ
    Vopr Virusol; 1968; 13(5):554-60. PubMed ID: 4303594
    [No Abstract]   [Full Text] [Related]  

  • 20. Inhibition of release of vaccinia virus by N1-isonicotinoly-N2-3-methyl-4-chlorobenzoylhydrazine.
    Kato N; Eggers HJ; Rolly H
    J Exp Med; 1969 Apr; 129(4):795-808. PubMed ID: 4974996
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.